Xie Chao-Qun, Chen Kai, Sun Hao-Xian, Dong Hui, Zhu Ying
Department of Spleen and Stomach Disease, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha 410007, China.
Zhen Ci Yan Jiu. 2023 Jul 25;48(7):625-34. doi: 10.13702/j.1000-0607.20220333.
To observe the effect of acupoint catgut embedding (CE) on Nod-like receptor protein 3 (NLRP3)/Caspase-1 signaling pathway in "deficiency-stasis" syndrome type ulcerative colitis (UC) rats, so as to explore its mechanisms underlying improvement of UC.
A total of 58 male SD rats were randomly divided into control group (10 rats) and model group (48 rats). The "deficiency-stasis" type UC model was established by gavage of adenine and folium sennae solution for 4 weeks, followed by clycter of mixture solution of 5% trinitro-benzene-sulfonic acid and 50% ethanol. A total of 44 UC rats were randomized into model, salicylazosulfapyridine (SASP), non-acupoint CE, and acupoint CE groups (11 rats in each group). The catgut embedment was applied to bilateral "Zusanli"(ST36), "Shenshu"(BL23), "Pishu"(BL20), "Dachangshu"(BL25), "Geshu" (BL17) and "Tianshu"(ST25), or non-acupoints (the fat muscles of the buttocks), separately, once every two weeks, 3 times altogether. Rats of the SASP group received gavage of SASP solution, and those of the other groups received gavage of same amount of normal saline, once daily for 42 days. The rat's general conditions and the colon length were recorded, the disease activity index (DAI, 0 to 4 points) and colonic mucosal damage index (CMDI, 0 to 5 points) were calculated. Histopathological changes of the colonic mucosa tissue were observed after HE staining, and the tissue damage index (TDI, 0 to 6 points) was given. The levels of serum NLRP3, interleukin (IL)-1β and IL-18 were measured by ELISA, and the expression levels of NLRP3, Caspase-1, apoptosis-associated speck-like protein (ASC), IL-1β and IL-18 mRNAs were measured by fluorescence quantitative PCR. The expression levels of NLRP3 and Caspase-1 proteins in the colon tissues were measured by Western blot, and the immunoactivity of colonic ASC was detected by immunohistochemistry.
Compared with the control group, the rats' body mass and colonic length were significantly decreased (<0.01), and DAI score, CMDI score, TDI score, contents of serum NLRP3, IL-1β and IL-18, expression levels of colonic NLRP3, ASC, Caspase-1, IL-1β and IL-18 mRNAs, and NLRP3 and Caspase -1 proteins as well as colonic ASC immunoactivity were significantly up-regulated in the model group (<0.01). Compared with the model group, both SASP and acupoint CE groups had a significant increase in body mass and colonic length (<0.01), and a marked decrease in DAI score, CMDI score, TDI score, contents of serum NLRP3, IL-1β and IL-18, expression levels of NLRP3, ASC, Caspase-1, IL-1β and IL-18 mRNAs and NLRP3 and Caspase-1 proteins and ASC immunoactivity (<0.01). The above indexes were improved in the acupoint CE group in relevant to those of the non-acupoint CE group (<0.01). HE staining of colonic mucosal tissue showed obvious ulcerative surface, destroyed recess, disordered arrangement of glands, mucosal edema and congestion, infiltration of a large number of inflammatory cells in the model group, which was obviously milder in both SASP and acupoint CE groups.
Acupoint embedding can alleviate colonic injury and inhibit inflammatory reaction in rats with "deficiency-stasis" type UC by down-regulating colonic NLRP3/Caspase-1 signaling.
观察穴位埋线对“虚瘀”证型溃疡性结肠炎(UC)大鼠Nod样受体蛋白3(NLRP3)/半胱天冬酶-1信号通路的影响,以探讨其改善UC的作用机制。
58只雄性SD大鼠随机分为对照组(10只)和模型组(48只)。采用腺嘌呤和番泻叶溶液灌胃4周,然后用5%三硝基苯磺酸和50%乙醇混合溶液灌肠的方法建立“虚瘀”型UC模型。44只UC大鼠随机分为模型组、柳氮磺胺吡啶(SASP)组、非穴位埋线组和穴位埋线组,每组11只。穴位埋线分别选取双侧“足三里”(ST36)、“肾俞”(BL23)、“脾俞”(BL20)、“大肠俞”(BL25)、“膈俞”(BL17)和“天枢”(ST25),或非穴位(臀部脂肪肌肉),每两周埋线1次,共3次。SASP组大鼠灌胃SASP溶液,其他组大鼠灌胃等量生理盐水,每日1次,共42天。记录大鼠一般情况及结肠长度,计算疾病活动指数(DAI,0至4分)和结肠黏膜损伤指数(CMDI,0至5分)。HE染色后观察结肠黏膜组织病理变化,给出组织损伤指数(TDI,0至6分)。采用ELISA法检测血清NLRP3、白细胞介素(IL)-1β和IL-18水平,采用荧光定量PCR法检测NLRP3、半胱天冬酶-1、凋亡相关斑点样蛋白(ASC)、IL-1β和IL-18 mRNA表达水平。采用Western blot法检测结肠组织中NLRP3和半胱天冬酶-1蛋白表达水平,采用免疫组化法检测结肠ASC免疫活性。
与对照组相比,模型组大鼠体重和结肠长度显著降低(<0.01),DAI评分、CMDI评分、TDI评分、血清NLRP3、IL-1β和IL-18含量、结肠NLRP3、ASC、半胱天冬酶-1、IL-1β和IL-18 mRNA表达水平以及NLRP3和半胱天冬酶-1蛋白表达水平及结肠ASC免疫活性显著上调(<0.01)。与模型组相比,SASP组和穴位埋线组大鼠体重和结肠长度均显著增加(<0.01),DAI评分、CMDI评分、TDI评分、血清NLRP3、IL-1β和IL-18含量、NLRP3、ASC、半胱天冬酶-1、IL-1β和IL-18 mRNA表达水平以及NLRP3和半胱天冬酶-1蛋白表达水平及ASC免疫活性均显著降低(<0.01)。穴位埋线组上述指标与非穴位埋线组相比有改善(<0.01)。结肠黏膜组织HE染色显示,模型组有明显溃疡面、隐窝破坏、腺体排列紊乱、黏膜水肿和充血,大量炎性细胞浸润,SASP组和穴位埋线组上述表现均明显减轻。
穴位埋线可通过下调结肠NLRP3/半胱天冬酶-1信号通路减轻“虚瘀”型UC大鼠结肠损伤,抑制炎症反应。